Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Restructure
Biotech
Aadi buys preclinical ADCs, sells Fyarro to reboot business
Aadi is transforming from a commercial business into a preclinical biotech by offloading its approved product and licensing ADCs for $44 million.
Nick Paul Taylor
Dec 20, 2024 3:54am
Alligator lets loose 70% of staff, sinking stock 53%
Dec 2, 2024 10:40am
Genentech to close cancer immunology research department
Aug 16, 2024 11:08am
Novartis closes San Diego R&D site as part of restructure plan
Jul 11, 2024 9:29am
Bayer’s biotech head departs as pharma eliminates role
Jun 11, 2024 12:57pm
Theravance takes another blow, cuts staff again in regroup
Feb 28, 2023 4:31am
